Dean’s Staff Awards Each year, the Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. The Dean's Staff Awards honours exceptional…
Read More
Health Research BC’s funding for 71 researchers through the 2022 Scholar and Research Trainee competitions will help develop, attract and retain BC’s best and brightest health researchers and support the…
Read More
Jason Gencher presented the RAFT-AF Trial which was a randomized, multicenter, open-label trial comparing ablation-based rhythm control to rate control among patients with high-burden paroxysmal (>4 episodes in 6 months) or persistent (duration <3 years) AFib, NYHA…
Read More
Miles Marchand presented the SODIUM-HF Trial which was an international, open-label, randomised, controlled trial comparing usual care according to local guidelines or a low sodium diet of less than 100 mmol (ie, <1500 mg/day) among patients…
Read More
Majeed Alosail presented the PACMAN-AMI Trial which was a double-blind, placebo-controlled, randomized clinical trial comparing the use of biweekly subcutaneous alirocumab to placebo, in addition to high-intensity statin therapy among patients undergoing percutaneous coronary intervention for acute myocardial…
Read More
Andy Dhaliwal presented the CHAP Trial which was an open-label, multicenter, randomized trial, comparing the use of antihypertensive medications to no treatment (unless severe hypertension developed) among pregnant women with mild chronic hypertension and singleton fetuses at a gestational age of…
Read More
River Jiang presented the DISCHARGE Trial which is a pragmatic, randomized trial comparing CT with Invasive Coronary Angiography (ICA) as initial diagnostic imaging strategies for guiding the treatment of patients with stable chest pain who…
Read More
Andrew Kochan presented the PARADISE-MI Trial. The trial's goal was to assess the efficacy and safety of sacubitril/valsartan compared with ramipril in the acute myocardial infarction (AMI) population. This trial enrolled 5661 patients with a duration…
Read More